News Conference News ACC 2019 My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay Shelley Wood April 05, 2019
News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Conference News ACC 2019 Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being Yael L. Maxwell March 28, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News ACC 2019 PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital Michael O'Riordan March 25, 2019
News Conference News ACC 2019 Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD Shelley Wood March 22, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Conference News ACC 2019 SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI Michael O'Riordan March 18, 2019
News Conference News ACC 2019 Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI Yael L. Maxwell March 18, 2019
News Conference News ACC 2019 Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry Caitlin E. Cox March 18, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019
News Opinion Off Script ACC 2019 Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound Kwan S. Lee March 17, 2019
News Conference News ACC 2019 New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead Michael O'Riordan March 17, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019
News Conference News ACC 2019 AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI Caitlin E. Cox March 17, 2019
Presentation ACC 2019 PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis Presenter: Martin B. Leon March 17, 2019
News Conference News ACC 2019 Apple Watch May Detect A-fib in the General Population, but at What Cost? Yael L. Maxwell March 16, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Opening Day at ACC 2019 Shelley Wood March 16, 2019